Aigen Investment Management LP Boosts Stock Position in Danaher Corporation (NYSE:DHR)

Key Points

• Aigen Investment Management LP increased its stake in Danaher Corporation by 126.4%, owning 18,124 shares valued at approximately $3.7 million as of the latest quarter.
• Danaher reported a quarterly earnings per share (EPS) of $1.80, exceeding estimates, and generated $5.94 billion in revenue, reflecting a 3.4% year-over-year growth.
• Analysts maintain a positive outlook for Danaher, with a current average rating of "Moderate Buy" and a target price of $247.61.

Aigen Investment Management LP boosted its position in Danaher Corporation (NYSE:DHR - Free Report) by 126.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,124 shares of the conglomerate's stock after buying an additional 10,119 shares during the quarter. Danaher makes up approximately 0.6% of Aigen Investment Management LP's portfolio, making the stock its 18th biggest position. Aigen Investment Management LP's holdings in Danaher were worth $3,715,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. FAS Wealth Partners Inc. boosted its stake in Danaher by 20.6% in the fourth quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after buying an additional 1,639 shares in the last quarter. MGO One Seven LLC boosted its stake in shares of Danaher by 485.7% during the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock valued at $5,145,000 after purchasing an additional 20,813 shares during the period. Asahi Life Asset Management CO. LTD. purchased a new stake in shares of Danaher during the first quarter valued at approximately $539,000. Horizon Financial Services LLC boosted its stake in shares of Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock valued at $1,681,000 after purchasing an additional 8,160 shares during the period. Finally, EFG Asset Management Americas Corp. boosted its stake in shares of Danaher by 13.1% during the first quarter. EFG Asset Management Americas Corp. now owns 36,080 shares of the conglomerate's stock valued at $7,396,000 after purchasing an additional 4,191 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on DHR shares. Guggenheim reissued a "buy" rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. TD Cowen increased their price objective on Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a research note on Wednesday, April 23rd. UBS Group dropped their price objective on Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research note on Wednesday, July 23rd. Robert W. Baird increased their price objective on Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a research note on Friday, July 18th. Finally, JPMorgan Chase & Co. dropped their price target on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Three investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and a consensus target price of $247.61.

Danaher Stock Up 1.7%

DHR traded up $3.56 during trading on Wednesday, reaching $209.28. The stock had a trading volume of 3,241,300 shares, compared to its average volume of 4,263,600. The stock's 50 day moving average is $198.95 and its two-hundred day moving average is $200.34. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $149.86 billion, a price-to-earnings ratio of 44.53, a P/E/G ratio of 2.79 and a beta of 0.73. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same period last year, the company earned $1.72 earnings per share. The company's revenue was up 3.4% on a year-over-year basis. As a group, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.